BRPI0511663A - composição compreendendo água e um componente de sólidos, processo, e, tablete revestido - Google Patents

composição compreendendo água e um componente de sólidos, processo, e, tablete revestido

Info

Publication number
BRPI0511663A
BRPI0511663A BRPI0511663-5A BRPI0511663A BRPI0511663A BR PI0511663 A BRPI0511663 A BR PI0511663A BR PI0511663 A BRPI0511663 A BR PI0511663A BR PI0511663 A BRPI0511663 A BR PI0511663A
Authority
BR
Brazil
Prior art keywords
dosage forms
coated tablet
composition
solid dosage
water
Prior art date
Application number
BRPI0511663-5A
Other languages
English (en)
Inventor
John C Clark
John J Michelucci
Deborah M Sherman
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of BRPI0511663A publication Critical patent/BRPI0511663A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Paints Or Removers (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

COMPOSIçãO COMPREENDENDO áGUA E UM COMPONENTE DE SóLIDOS, PROCESSO, E, TABLETE REVESTIDO São fornecidas composições particularmente úteis como revestimentos para formas de dosagem sólida de agentes terapêuticos, como o são formas de dosagem sólida compreendendo tais revestimentos, processos para preparar tais formas de dosagem sólida e os produtos desses processos. As composições de revestimento geralmente fornecem excelente resistência a fissura, mesmo quando aplicadas a núcleos de tablete flexíveis/intumescíveis, tais como núcleos tipo hidrogel. As composições também exibem excelentes características de bloqueio de odor.
BRPI0511663-5A 2004-06-07 2005-06-07 composição compreendendo água e um componente de sólidos, processo, e, tablete revestido BRPI0511663A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57766804P 2004-06-07 2004-06-07
PCT/US2005/019972 WO2005120466A2 (en) 2004-06-07 2005-06-07 Sugar coatings and methods therefor

Publications (1)

Publication Number Publication Date
BRPI0511663A true BRPI0511663A (pt) 2008-01-02

Family

ID=35351681

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0511663-5A BRPI0511663A (pt) 2004-06-07 2005-06-07 composição compreendendo água e um componente de sólidos, processo, e, tablete revestido

Country Status (23)

Country Link
US (2) US20050271724A1 (pt)
EP (1) EP1753407B1 (pt)
JP (1) JP5000509B2 (pt)
CN (1) CN101267809A (pt)
AR (1) AR049142A1 (pt)
AU (1) AU2005251793B2 (pt)
BR (1) BRPI0511663A (pt)
CA (1) CA2566771A1 (pt)
CR (1) CR8778A (pt)
EC (1) ECSP067049A (pt)
ES (1) ES2623363T3 (pt)
GT (1) GT200500141A (pt)
IL (1) IL179537A0 (pt)
MX (1) MXPA06014229A (pt)
NO (1) NO20070091L (pt)
NZ (1) NZ551676A (pt)
PA (1) PA8636001A1 (pt)
PE (1) PE20060245A1 (pt)
RU (1) RU2428178C2 (pt)
SV (1) SV2006002136A (pt)
TW (1) TW200602089A (pt)
UA (1) UA86413C2 (pt)
WO (1) WO2005120466A2 (pt)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0602397C1 (pt) * 2006-04-20 2009-11-24 Unicamp composições farmacêuticas para o tratamento das doenças gordurosas do fìgado, obesidade e demais doenças associadas à sìndrome metabólica e métodos de tratamento utilizando-se as referidas composições
WO2007148786A1 (ja) * 2006-06-23 2007-12-27 Takeda Pharmaceutical Company Limited 安定化された固形製剤
JP5198001B2 (ja) * 2006-06-23 2013-05-15 武田薬品工業株式会社 安定化された固形製剤
CN101495101B (zh) * 2006-07-25 2012-02-29 兴和株式会社 糖衣制剂及其制造方法
CN101541326A (zh) * 2006-11-29 2009-09-23 惠氏公司 雌激素/选择性雌激素受体调节剂（serm）和雌激素/孕酮双层药片
CN101631536A (zh) * 2007-01-12 2010-01-20 惠氏公司 片中片组合物
US20090012146A1 (en) * 2007-07-02 2009-01-08 Giridhar Reddy Buggana Solubility-enhanced pharmaceutical compositions comprising zafirlukast
US20090232897A1 (en) * 2008-03-14 2009-09-17 Bijayananda Sahoo Pharmaceutical compositions comprising conjugated estrogens
WO2009135067A1 (en) * 2008-05-01 2009-11-05 Wyeth Pharmaceutical polish formulations
WO2009158584A1 (en) * 2008-06-27 2009-12-30 Wyeth Dual adhesive technology
CN101744725B (zh) * 2008-12-09 2013-04-17 北京华素制药股份有限公司 缓释微丸包衣生产工艺参数的优化方法
WO2010075080A1 (en) * 2008-12-15 2010-07-01 Somnus Therapeutics, Inc. A method of treating insomnia
RU2410100C2 (ru) * 2009-03-30 2011-01-27 Александр Владимирович Диковский Фармацевтическая композиция ингибитора протонной помпы и пребиотика для лечения язвенных поражений желудка и 12-перстной кишки
US20110052687A1 (en) * 2009-08-26 2011-03-03 Glenmark Generics Ltd Extended release pharmaceutical composition of paliperidone
EP2477614A2 (en) * 2009-09-17 2012-07-25 Cadila Healthcare Limited Pharmaceutical compositions for reducing alcohol-induced dose dumping
US8663671B2 (en) 2009-11-05 2014-03-04 Philip Morris Usa Inc. Methods and compositions for producing hydrogel capsules coated for low permeability and physical integrity
MX339408B (es) * 2010-03-09 2016-05-24 Alkermes Pharma Ireland Ltd Composiciones farmaceuticas entericas resistentes al alcohol.
EP2568973A2 (en) 2010-05-11 2013-03-20 Sensient Colors LLC Film coating composition and methods of making and using the same
SI2665477T1 (sl) * 2011-01-20 2016-02-29 Bionevia Pharmaceuticals Inc. Modificirano sproščanje epalrestata ali njegovega derivata in metode za uporabo le-teh
US8846089B2 (en) * 2011-06-03 2014-09-30 Wakunaga Pharmaceutical Co., Ltd. Sugar-coated preparation and production method for the same
CN103385876B (zh) * 2012-05-08 2016-01-13 四川滇虹医药开发有限公司 一种夫罗曲坦的药物组合物及其制备方法
FR2996128B1 (fr) * 2012-09-28 2015-01-02 Inneov Lab Utilisation d'une association de taurine ou un de ses derives, et d'extrait de raisins pour ameliorer la qualite des ongles.
CN103977427A (zh) * 2014-05-08 2014-08-13 王�琦 一种糖衣产气粉配方及其制备方法
WO2015186693A1 (ja) * 2014-06-02 2015-12-10 ニプロ株式会社 レーザー印刷用錠剤及びその製造方法
WO2016108250A1 (en) 2015-01-01 2016-07-07 Ideal Cures Pvt. Ltd. Novel film coating composition
JP6737793B2 (ja) * 2015-01-29 2020-08-12 ノヴォ ノルディスク アー／エス 錠剤コアとポリビニルアルコールコーティングとを含む経口インスリン投与のための医薬組成物
RU2588840C1 (ru) * 2015-03-26 2016-07-10 Общество с ограниченной ответственностью ООО "ВАЛЕНТА-ИНТЕЛЛЕКТ" Таблетки кветиапина с пролонгированным высвобождением и способ их получения
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
US10232045B2 (en) * 2016-08-04 2019-03-19 Bpsi Holdings Llc Easy to swallow coatings and substrates coated therewith
FR3069545B1 (fr) * 2017-07-27 2020-10-16 Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic Composition d'enrobage exempte de dioxyde de titane
MX2019008440A (es) * 2019-07-15 2021-01-18 Dva Farma Mexicana S A De C V Composiciones de recubrimientos en pelicula para tabletas con brillantez incrementada, procedimiento de preparacion y aplicacion.

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2565115A (en) 1948-10-28 1951-08-21 Squibb & Sons Inc Method of obtaining a conjugated estrogen preparation
US2720483A (en) 1951-02-21 1955-10-11 Olin Mathieson Method of obtaining a conjugatedestrogen preparation
US3487152A (en) * 1967-02-07 1969-12-30 Hoffmann La Roche Tablets containing 7 - chloro - 2 - methylamino - 5 - phenyl - 3h - 1,4 - benzodiazepine-4-oxide and conjugated estrogenic substances
JPS625910A (ja) * 1985-07-02 1987-01-12 Shin Etsu Chem Co Ltd 薄層糖衣錠の製造方法
US5210081A (en) 1992-02-26 1993-05-11 American Home Products Corporation Alkali metal 8,9-dehydroestrone sulfate esters
AU680019B2 (en) * 1993-08-30 1997-07-17 Warner-Lambert Company Llc Tablet coating based on a melt-spun mixture of a saccharide and apolymer
US5759577A (en) * 1995-01-17 1998-06-02 American Home Products Corporation Controlled release of steroids from sugar coatings
US5547948A (en) * 1995-01-17 1996-08-20 American Home Products Corporation Controlled release of steroids from sugar coatings
WO1997004752A1 (en) * 1995-07-26 1997-02-13 Duramed Pharmaceuticals, Inc. Pharmaceutical compositions of conjugated estrogens and methods for their use
US6248391B1 (en) * 1997-07-16 2001-06-19 Bpsi Holdings, Inc. Bright white film coatings and film coating compositions therefor
AU4040800A (en) * 1999-03-29 2000-10-16 American Home Products Corporation Coating system
US6630166B1 (en) * 2001-02-12 2003-10-07 Watson Pharmaceuticals, Inc. Compositions for conjugated estrogens and associated methods
US20030070584A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
AU2003213337A1 (en) * 2002-03-14 2003-09-22 Daiichi Suntory Pharma Co., Ltd. Tablet containing pilsicainide hydrochloride (wet)

Also Published As

Publication number Publication date
US20110136772A1 (en) 2011-06-09
AU2005251793A1 (en) 2005-12-22
TW200602089A (en) 2006-01-16
RU2006140093A (ru) 2008-07-20
WO2005120466A2 (en) 2005-12-22
UA86413C2 (ru) 2009-04-27
PE20060245A1 (es) 2006-05-03
WO2005120466A3 (en) 2007-04-19
JP5000509B2 (ja) 2012-08-15
PA8636001A1 (es) 2006-05-16
NZ551676A (en) 2010-11-26
AU2005251793B2 (en) 2010-07-15
IL179537A0 (en) 2007-05-15
US20050271724A1 (en) 2005-12-08
NO20070091L (no) 2007-01-05
JP2008501803A (ja) 2008-01-24
RU2428178C2 (ru) 2011-09-10
MXPA06014229A (es) 2007-05-04
EP1753407A2 (en) 2007-02-21
CN101267809A (zh) 2008-09-17
CA2566771A1 (en) 2005-12-22
EP1753407B1 (en) 2017-03-08
ECSP067049A (es) 2007-02-28
GT200500141A (es) 2006-01-10
SV2006002136A (es) 2006-02-15
AR049142A1 (es) 2006-06-28
ES2623363T3 (es) 2017-07-11
CR8778A (es) 2007-10-01

Similar Documents

Publication Publication Date Title
BRPI0511663A (pt) composição compreendendo água e um componente de sólidos, processo, e, tablete revestido
MX2010001460A (es) Composiciones y metodos para tratamiento de semillas.
AR062250A1 (es) Recubrimientos de poliurea / politiourea
CL2011001497A1 (es) Compuestos derivados de heterociclos, modulador de gpr120; composicion farmaceutica; y su uso para el tratamiento de diabetes tipo i,ii y sindrome metabolico.
BR112017023722A2 (pt) composição formadora de película curável, substrato revestido e método para revestir um substrato
AR058818A1 (es) Composiciones que contienen un polimero funcional de silanol y peliculas de recubrimiento hidrofilicas relacionadas
CL2011003082A1 (es) Compuestos derivados de [1,2,4]triazolo[1,5-a]piridina, inhibidores de jak2 o fak; composiciones farmaceuticas que los comprenden; y su uso para el tratamiento de una enfermedad hiperproliferativa.
WO2007084841A3 (en) Sulfonyl substituted 1h-indoles as ligands for the 5-hydroxytryptamine receptors
BR112013021231A2 (pt) revestimentos super-hidrofóbicos e oleofóbicos com sistemas ligantes de baixo voc
BRPI0810552A2 (pt) Composição de substância ativa, processos para preparar uma composição de substância ativa, e para preparar sementes contenda substância ativa, uso da composição de substância ativa, sementes, e, composição aquosa.
ATE510873T1 (de) Verwendung hochfunktioneller, hochverzweigter polyetheraminpolyole zur beschichtung von oberflächen
CL2007003756A1 (es) Compuestos derivados de pirazolo-quinazolina sustituidos, moduladores de la actividad de proteina quinasas; proceso de preparacion; composicion farmaceutica; y uso para el tratamiento del cancer.
CL2007002188A1 (es) Compuestos derivados de heteroarilaminas; procedimiento de preparacion; composicion farmceutica; y uso del compuesto para tratar el crecimiento celular anormal.
EA200901653A1 (ru) ОПОСРЕДУЕМОЕ PHKi ИНГИБИРОВАНИЕ ЭКСПРЕССИИ АЛЬФА-EnaC
NI201000044A (es) Bromhidrato de bupropión y aplicaciones terapéuticas
CL2007003495A1 (es) Compuestos derivados de heterociclos condensados sustituidos, inhibidores de la actividad de la akt; composicion farmaceutica; y uso para el tratamiento o prevencion del cancer.
BRPI0703892A (pt) revestimento aquoso à base de uma mistura de aglutinantes como revestimento de base
CL2007001022A1 (es) Compuestos derivados de 1h-indol-2-carboxamida; procedimiento de preparacion, composicion farmaceutica; y uso para el tratamiento y/o prevencion de enfermedades asociadas con la modulacion de los receptores de h3 tal como obesidad, diabetes tipo ii y
BRPI0606574A2 (pt) métodos de ativação de um revestimento orgânico e de preparação de um tratamento de ativação, substrato revestido e tratamento de ativação para um revestimento orgânico
CL2007003733A1 (es) Compuestos derivados de indolin-2-ona, bencimidazol-2-ona y benzoxazol-2-ona, moduladores de serina palmitoiltransferasa; composicion farmaceutica; y uso para el tratamiento de enfermedades tales como diabetes tipo 1 y 2, obesidad, aterosclerosis, hi
ATE499420T1 (de) Abziehbare temporäre beschichtung
NI201000015A (es) Bromhidrato de bupropión y aplicaciones terapéuticas
NO20082285L (no) 3-aminosyklopentankarboksamider som modulatorer av kjemokinreseptorer
EP2702988A3 (en) Novel compositions and methods for treating hyperproliferative diseases
BR112013016067A2 (pt) "composição reticulável e/ou endurecível, composição e elastómero de silicone, uso da composição de silicone, suporte sólido revestido e processo de revestimento sobre um suporte flexível"

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2258 DE 15/04/2014.